These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Daptomycin as a promising antimicrobial agent for the treatment of serious infections caused by resistant gram-positive organisms. Tarai B; Das P; Kumar D Indian J Med Microbiol; 2014; 32(3):353-4. PubMed ID: 25008844 [No Abstract] [Full Text] [Related]
31. [Fluoroquinolones: a new era in antibiotic therapy?]. Fiaccadori F Ann Ital Med Int; 1992; 7(1):46-50. PubMed ID: 1524947 [TBL] [Abstract][Full Text] [Related]
32. The epidemiology of bacterial resistance to quinolones. Acar JF; O'Brien TF; Goldstein FW; Jones RN Drugs; 1993; 45 Suppl 3():24-8. PubMed ID: 7689447 [TBL] [Abstract][Full Text] [Related]
33. What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone. Cho JC; Crotty MP; White BP; Worley MV Pharmacotherapy; 2018 Jan; 38(1):108-121. PubMed ID: 29059465 [TBL] [Abstract][Full Text] [Related]
34. Update on cross-resistance of fluoroquinolones. Garau J Int J Clin Pract Suppl; 2000 Dec; (115):94-8. PubMed ID: 11219309 [No Abstract] [Full Text] [Related]
35. [Efflux pumps of gram-positive bacteria and resistance to fluoroquionolones]. Egorov AM; Sazykin IuO Antibiot Khimioter; 2001; 46(8):3-5. PubMed ID: 11871317 [No Abstract] [Full Text] [Related]
36. Fluoroquinolones: action and resistance. Drlica K; Malik M Curr Top Med Chem; 2003; 3(3):249-82. PubMed ID: 12570763 [TBL] [Abstract][Full Text] [Related]
37. Activity of newer fluoroquinolones in vitro against gram-positive bacteria. Eliopoulos GM Drugs; 1999; 58 Suppl 2():23-8. PubMed ID: 10553701 [TBL] [Abstract][Full Text] [Related]
38. New infective problems with old gram-positive pathogens: setting the stage. Sanders WE Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S1-2. PubMed ID: 7729465 [No Abstract] [Full Text] [Related]